TABLE 1.
Clinical characteristics of the pancreatic cancer patients.
| Characteristics | Type | Total | Test | Train | P-value |
| Age | ≤65 | 93(52.54%) | 52(59.09%) | 41(46.07%) | 0.1131 |
| >65 | 84(47.46%) | 36(40.91%) | 48(53.93%) | ||
| Gender | Male | 97(54.8%) | 50(56.82%) | 47(52.81%) | 0.7004 |
| Female | 80(45.2%) | 38(43.18%) | 42(47.19%) | ||
| Grade | G1–2 | 125(70.62%) | 66(75%) | 59(66.29%) | 0.4347 |
| G3–4 | 50(28.25%) | 21(23.86%) | 29(32.58%) | ||
| Unknown | 2(1.13%) | 1(1.14%) | 1(1.12%) | ||
| T | T1–2 | 31(17.51%) | 10(11.36%) | 21(23.6%) | 0.1007 |
| T3–4 | 144(81.36%) | 77(87.5%) | 67(75.28%) | ||
| Unknown | 2(1.13%) | 1(1.14%) | 1(1.12%) | ||
| N | N0 | 49(27.68%) | 23(26.14%) | 26(29.21%) | 0.8244 |
| N1 | 123(69.49%) | 62(70.45%) | 61(68.54%) | ||
| Unknown | 5(2.82%) | 3(3.41%) | 2(2.25%) | ||
| Stage | Stage I–II | 167(94.35%) | 84(95.45%) | 83(93.26%) | 0.788 |
| Stage III–IV | 7(3.95%) | 3(3.41%) | 4(4.49%) | ||
| Unknown | 3(1.69%) | 1(1.14%) | 2(2.25%) | ||
| Alcohol | Yes | 101(57.06%) | 51(57.95%) | 50(56.18%) | 0.8447 |
| No | 64(36.16%) | 32(36.36%) | 32(35.96%) | ||
| Unknown | 12(6.78%) | 5(5.68%) | 7(7.87%) | ||
| Diabetes | Yes | 38(21.47%) | 21(23.86%) | 17(19.1%) | 0.6767 |
| No | 108(61.02%) | 51(57.95%) | 57(64.04%) | ||
| Unknown | 31(17.51%) | 16(18.18%) | 15(16.85%) | ||
| Radiation | Yes | 32(18.08%) | 18(20.45%) | 14(15.73%) | 0.6901 |
| No | 101(57.06%) | 48(54.55%) | 53(59.55%) | ||
| Unknown | 44(24.86%) | 22(25%) | 22(24.72%) | ||
| Chemotherapy | Yes | 109(61.58%) | 55(62.5%) | 54(60.67%) | 0.6287 |
| No | 62(35.03%) | 29(32.95%) | 33(37.08%) | ||
| Unknown | 6(3.39%) | 4(4.55%) | 2(2.25%) |